Endoscopic Assessment and Prediction of Microbiome-modifying Interventions
microbiome
1 other identifier
interventional
45
1 country
1
Brief Summary
The investigators would like to examine the extent of gut microbiome rehabilitation in healthy people after the consumption of antibiotics. Outcomes of probiotic treatment versus bacteriotherapy will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 13, 2017
CompletedFirst Posted
Study publicly available on registry
July 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedJuly 21, 2017
July 1, 2017
6.9 years
July 13, 2017
July 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Microbiome composition
stool samples
1 year
Secondary Outcomes (1)
Microbiome composition
1 month
Study Arms (3)
No intervention
NO INTERVENTIONNo intervention after antibiotic treatment.
Probiotic microbiome rehabilitation
ACTIVE COMPARATORProbiotic treatment after antibiotic treatment.
Bacteriotherapy microbiome rehabilitation
ACTIVE COMPARATORBacteriotherapy after antibiotic treatment.
Interventions
4 weeks of probiotic treatment after 7 days of antibiotics (Metronidazole+Ciprofloxacin)
Bacteriotherapy (autologous fecal microbiota transplantation) after 7 days of antibiotics (Metronidazole+Ciprofloxacin)
Eligibility Criteria
You may qualify if:
- Healthy volunteers
- Age: 18 years and up
- Gender: women and men
You may not qualify if:
- Pregnancy
- Age under 18 years
- antibiotic treatment 3 months prior to enrollment
- Viral Hepatitis
- HIV positive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tel-Aviv Sourasky Medical Centerlead
- Weizmann Institute of Sciencecollaborator
Study Sites (1)
Department of Gastroentherology
Tel Aviv, 64239, Israel
Study Officials
- PRINCIPAL INVESTIGATOR
Zamir Halpern, MD
Tel-Aviv Sourasky Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2017
First Posted
July 14, 2017
Study Start
February 1, 2013
Primary Completion
December 30, 2019
Study Completion
December 30, 2020
Last Updated
July 21, 2017
Record last verified: 2017-07